ArticleFrontiers in medicine2026

Early dynamic immune-inflammatory and nutritional recovery signature is associated with durable benefit and early progression in advanced non-small cell lung cancer receiving first-line PD-1/PD-L1 inhibitor-based therapy: a real-world retrospective cohort study.

Tingting Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.